STK11 and acute myeloid leukemia: Loss of LKB1 activates the mTOR pathway and promotes cell growth, survival and tumorigenesis in acute myeloid leukemia, squamous cell carcinoma of skin, and squamous cell carcinoma of lung via LKB1/AMPK regulation [19–21].